Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C
Open Access
- 1 May 1993
- journal article
- research article
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 57 (5), 787S-797S
- https://doi.org/10.1093/ajcn/57.5.787s
Abstract
For the prolongation of life expectancy and reduction of ischemic heart disease (IHD) dietary guidelines generally recommend lowering saturated mammalian fat with partial replacement by vegetable oils and increasing generously vegetables, legumes, and fruits, which provide more essential antioxidants. Plasma antioxidants as assayed in epidemiological studies of complementary type (ie the cross-cultural MONICA Vitamin Substudy reevaluation considering the “Finland-Factor”, the Edinburgh Angina-Control Study, and the Basel Prospective Study) consistently revealed an increased risk of IHD (and stroke) at low plasma concentrations of antioxidants, with the rank order as follows: lipid-standardized vitamin E ⪢ carotene = vitamin C > vitamin A, independently of classical IHD risk factors. Decreasing IHD risk through nutrition may be possible when plasma concentrations have the following values: > 27.5–30.0 µmol vitamin E/L, 0.4–0.5 µmol carotene/L, 40-50 µmol vitamin C/L and 2.2–2.8 µmol vitamin A/L. Thus, previous prudent regimens may now be updated, aiming at an optimal status of all essential and synergistically linked antioxidants.Keywords
This publication has 47 references indexed in Scilit:
- Probucol treatment affects the cellular composition but not anti-oxidized low density lipoprotein immunoreactivity of plaques from Watanabe heritable hyperlipidemic rabbits.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Additional Antilipoperoxidant Activities of Alpha-Tocopherol and Ascorbic Acid on Membrane-Like Systems Are Potentiated by RutinPharmacology, 1991
- Oxidation of cholesteryl linoleate by human monocyte-macrophages in vitroAtherosclerosis, 1990
- Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoproteinAtherosclerosis, 1990
- Cancer Mortality and Vitamin E StatusAnnals of the New York Academy of Sciences, 1989
- Beyond CholesterolNew England Journal of Medicine, 1989
- I and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL-cholesterol levels in FinlandAtherosclerosis, 1988
- Plasma Vitamin C and Cancer Death: The Prospective Basel StudyAnnals of the New York Academy of Sciences, 1987
- Apolipoprotein E polymorphism, serum lipids and occurrence of ‘double pre-betalipoproteinemia’ (DPBL) in subjects from two different populationsAtherosclerosis, 1987
- VITAMIN A, CARDIOVASCULAR RISK FACTORS, AND MORTALITYThe Lancet, 1982